Interleukin-5 Antagonist [EPC]: Side Effects & Safety Data for 2 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Interleukin-5 Antagonist [EPC] includes 2 drugs with a combined 43,627 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
2
Drugs in Class
43,627
Combined Reports
All Interleukin-5 Antagonist [EPC] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| MEPOLIZUMAB | Nucala | 43,006 | 3,158 | 13,819 | 7.3% |
| RESLIZUMAB | CINQAIR | 621 | 15 | 121 | 2.4% |
Common Side Effects in Interleukin-5 Antagonist [EPC] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Asthma | 11,115 | 291 |
| Dyspnoea | 9,278 | 567 |
| Wheezing | 6,133 | 552 |
| Product dose omission issue | 5,880 | 88 |
| Cough | 4,613 | 46 |
| Pneumonia | 4,133 | 578 |
| Therapeutic product effect incomplete | 4,120 | 347 |
| Drug ineffective | 3,960 | 567 |
| Loss of personal independence in daily activities | 3,577 | 179 |
| Fatigue | 2,685 | 479 |